Trulieve Cannabis Corp. — Form 8-K Summary
Business Context and Reporting Period
Trulieve Cannabis Corp. filed a Form 8-K under Item 4.01 regarding a change in its independent registered public accounting firm. The audit committee approved the change on March 25, 2024; the report was signed March 29, 2024. The appointment applies to the fiscal year ending December 31, 2024.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics.
Material Changes
- Marcum LLP was dismissed effective March 25, 2024.
- WithumSmith+Brown, PC was appointed as the successor independent registered public accounting firm, with its engagement effective March 28, 2024.
- Marcum’s audit opinions on the 2023 and 2022 consolidated financial statements contained no adverse opinion, disclaimer, or qualification relating to uncertainty, audit scope, or accounting principles.
- Marcum issued adverse opinions on the effectiveness of internal control over financial reporting as of December 31, 2023 and December 31, 2022 because of material weaknesses.
Management Commentary, Risks, and Unusual Items
The company reported no disagreements with Marcum regarding accounting principles, financial statement disclosure, or audit scope or procedures, and no reportable events other than the disclosed material weaknesses.
The material weaknesses involved ineffective information technology general controls over user access and change management, ineffective management review controls related to inventory valuation, and, for 2022, ineffective controls for identifying, evaluating, and accounting for variable interest entities. The company stated that remediation efforts remain ongoing.
Neither the company nor anyone acting on its behalf consulted Withum during the relevant periods regarding accounting principles, audit opinions, disagreements, or reportable events.
Investor Verification Priorities
- Verify the status and effectiveness of remediation for the material weaknesses in the company’s Form 10-K and subsequent filings.
- Review Withum’s 2024 audit reports and any changes in internal-control conclusions.
- Review Exhibit 16.1, Marcum’s March 29, 2024 letter to the SEC, for Marcum’s response to the company’s disclosures.
- Confirm the effective dates and scope of Withum’s engagement and any subsequent auditor-related disclosures.